BDBM561741 US11390631, Example 278::US12268694, Example 278

SMILES C[C@H]1CN(CCO1)c1cc(cnc1-c1nnc(N[C@H]2N=C(c3ccccc3)c3ccccc3NC2=O)o1)C(F)(F)F

InChI Key InChIKey=JAECRVGVHGDQEK-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 561741   

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561741(US11390631, Example 278 | US12268694, Example 278)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561741(US11390631, Example 278 | US12268694, Example 278)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561741(US11390631, Example 278 | US12268694, Example 278)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561741(US11390631, Example 278 | US12268694, Example 278)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent